Social Media Working Group for Medical Device Companies
The majority of medical technology marketers navigating the social media waters have been waiting for an update or course of direction from the FDA regarding social media. Since holding a public hearing in 2009 on the “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools,” the FDA really hadn’t issued any guidance on what medical device companies wanted most—how to respond to adverse-event reporting via the emerging medium of electronic media.
As a healthcare public relations agency, we are constantly speaking with clients about Facebook, Twitter, Linked In and other vehicles to reach key audiences. While some medical device and pharma companies have jumped right in, others are more cautious, wanting to hear from the FDA before making a splash (if you let me continue with my water metaphors!).
In December, 2011, the FDA came out with a Draft Guidance but instead of focusing on adverse-even reporting like people expected, it provided recommendations for responding to unsolicited requests for off-label information related to their products. Check out the full report from the FDA.
This will most likely be a hot topic for discussion at the first meeting of the MassMEDIC working group on social media which is being held on Friday, February 3 (8:00 am) at Schwartz MSL. With participants from Philips, Palomar, Smith & Nephew and Vention Medical and moderated by Schwartz MSL Healthcare Practice Leader Jim Weinrebe, we expect a lively and educational session focused on how marketing, legal, regulatory and HR can work collaboratively. The event is open to all MassMEDIC members. Check back here for insights from the group that will be developing best practices for members.
Posted by Lauren Arnold on January 31, 2012 at 2:47 PM
